algecia 50 mg harde capsules
elpen pharmaceutical co. inc. 95 marathonos ave 190 09 pikermi attikis (griekenland) - pregabaline - capsule, hard - gelatine (e 441) ; lactose 1-water ; maÏszetmeel ; talk (e 553 b) ; titaandioxide (e 171), - pregabalin
noxap 200 ppm mol/mol, medicinaal gas, samengeperst
air products nederland b.v. boyneweg 10 3197 lk rotterdam - stikstofoxide 200 ppm mol/mol - medicinaal gas, samengeperst - stikstof (e 941), - nitric oxide
noxap 800 ppm mol/mol, medicinaal gas, samengeperst
air products nederland b.v. boyneweg 10 3197 lk rotterdam - stikstofoxide 800 ppm mol/mol - medicinaal gas, samengeperst - stikstof (e 941), - nitric oxide
glucose 30 % inf. opl. i.v. flac.
dechra veterinary products - watervrij dextrose 300 mg/ml - oplossing voor infusie - 30 % - glucosemonohydraat - glucose - rund; geit; schaap
raptiva
serono europe limited - efalizumab - psoriasis - immunosuppressiva - behandeling van volwassen patiënten met matige tot ernstige chronische plaque-psoriasis die hebben gefaald om te reageren op, of die een contra-indicatie voor, of intolerant zijn voor andere systemische therapieën inclusief ciclosporine, methotrexaat en puva (zie punt 5. 1 - klinische werkzaamheid).
kymriah
novartis europharm limited - tisagenlecleucel - precursor b-cell lymphoblastic leukemia-lymphoma; lymphoma, large b-cell, diffuse - andere antineoplastische middelen - kymriah is indicated for the treatment of:• paediatric and young adult patients up to and including 25 years of age with b cell acute lymphoblastic leukaemia (all) that is refractory, in relapse post transplant or in second or later relapse. • adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl) after two or more lines of systemic therapy. • adult patients with relapsed or refractory follicular lymphoma (fl) after two or more lines of systemic therapy.
neupopeg
dompé biotec s.p.a. - pegfilgrastim - neutropenia; cancer - immunostimulants, - vermindering van de duur van neutropenie en de incidentie van koorts neutropenie bij patiënten behandeld met cytotoxische chemotherapie voor maligniteit (met uitzondering van chronische myeloïde leukemie en myelodysplastic syndromes).
pombiliti
amicus therapeutics europe limited - cipaglucosidase alfa - glycogeen opslag ziekte type ii - andere maagdarmkanaal en metabolisme producten, - pombiliti (cipaglucosidase alfa) is a long-term enzyme replacement therapy used in combination with the enzyme stabiliser miglustat for the treatment of adults with late-onset pompe disease (acid α-glucosidase [gaa] deficiency).
galvus
novartis europharm limited - vildagliptine - diabetes mellitus, type 2 - geneesmiddelen die worden gebruikt bij diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.
jalra
novartis europharm limited - vildagliptine - diabetes mellitus, type 2 - dipeptidyl peptidase 4 (dpp-4) inhibitors, drugs used in diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 en 5. 1 voor de beschikbare gegevens over verschillende combinaties).